Evergrande Health Industry Group Limited provided earnings guidance for the year ended December 31, 2018. For the period the company expected to record net loss for the year ended 31 December 2018 of approximately RMB 1.4 billion, whereas the net profit of the Company for the year ended 31 December 2017 was approximately RMB 300 million. The Company expects the net loss is primarily attributable to the following factors the performance of the health management segment of the Group is expected to be stable, and the net profit recorded for 2018 is expected to be similar to that of 2017; and the new energy vehicle segment of the Group is expected to record a net loss in 2018 of approximately RMB 1.7 billion, as the Group has accounted for losses in its investment in Smart King Ltd. in 2018 through the equity accounting method, incurred interest expense in respect of the relevant loans and other expenses.